Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 Feb 15;176(3):687–696. doi: 10.1007/s10549-019-05165-4

Table 3.

Metabolic pathways associated with breast cancer risk

Discovery Validation
Metabolic pathway P value Impact factor P value Impact factor
Glycerophospholipid metabolism 2.17E-05 0.314 0.071 0.205
Sphingolipid metabolism 2.12E-04 0.283 Not observed
Citrate cycle (TCA cycle) 9.65E-04 0.236 0.012 0.090
Butanoate metabolism 0.013 0.108 0.076 0.040
D-Arginine and D-ornithine metabolism 0.014 0.500 Not observed
Alanine, aspartate and glutamate metabolism 0.017 0.003 0.119 0.003
Ascorbate and aldarate metabolism 0.019 0.049 0.310 0.033
Arginine and proline metabolism 0.031 0.096 0.011 0.120
Pyruvate metabolism 0.037 0.320 Not observed
Linoleic acid metabolism 0.046 0.656 0.005 0.656
Nicotinate and nicotinamide metabolism 0.081 0.017 0.095 0.038
Caffeine metabolism 0.084 0.045 0.413 0.015